第一单位：
Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Hematologic Malignancies and Bone Marrow Transplantation Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
作者：
Tania,Jain [1]
;
Merav,Bar [2]
;
Ankit J,Kansagra [3]
;
Elise A,Chong [4]
;
Shahrukh K,Hashmi [5]
;
Sattva S,Neelapu [6]
;
Michael,Byrne [7]
;
Elad,Jacoby [8]
;
Aleksandr,Lazaryan [9]
;
Caron A,Jacobson [10]
;
Stephen M,Ansell [11]
;
Farrukh T,Awan [3]
;
Linda,Burns [12]
;
Veronika,Bachanova [13]
;
Catherine M,Bollard [14]
;
Paul A,Carpenter [15]
;
John F,DiPersio [16]
;
Mehdi,Hamadani [17]
;
Helen E,Heslop [18]
;
Joshua A,Hill [19]
;
Krishna V,Komanduri [20]
;
Craig A,Kovitz [21]
;
Hillard M,Lazarus [22]
;
Justin M,Serrette [23]
;
Mohamad,Mohty [24]
;
David,Miklos [25]
;
Arnon,Nagler [7]
;
Steven Z,Pavletic [26]
;
Bipin N,Savani [7]
;
Stephen J,Schuster [4]
;
Mohamed A,Kharfan-Dabaja [27]
;
Miguel-Angel,Perales [28]
;
Yi,Lin [29]
作者单位：
Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Hematologic Malignancies and Bone Marrow Transplantation Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
[1]
Division of Clinical Research, Fred Hutchinson Cancer Research Center and Department of Medicine, University of Washington, Seattle, Washington.
[2]
Department of Hematology and Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
[3]
Lymphoma Program, Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania.
[4]
Division of Hematology, Mayo Clinic, Rochester, Minnesota; Oncology Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
[5]
Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas.
[6]
Division of Hematology and Medical Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
[7]
The Chaim Sheba Medical Center, Tel-Hashomer, Affiliated with the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
[8]
Blood and Marrow Transplant and Cellular Immunotherapy Program, Moffitt Cancer Center, Tampa, Florida.
[9]
Immune Effector Cell Therapy Program, Dana-Farber Cancer Institute, Boston, Massachusetts.
[10]
Division of Hematology, Mayo Clinic, Rochester, Minnesota.
[11]
National Marrow Donor Program and Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota.
[12]
Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota.
[13]
Center for Cancer and Immunology Research, Children's National Health System, Washington, DC.
[14]
Division of Clinical Research, Fred Hutchinson Cancer Research Center and Department of Medicine, University of Washington, Seattle, Washington; Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington.
[15]
Division of Oncology, Washington University School of Medicine, St Louis, Missouri.
[16]
Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
[17]
Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.
[18]
Division of Clinical Research, Fred Hutchinson Cancer Research Center and Department of Medicine, University of Washington, Seattle, Washington; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
[19]
Division of Transplantation and Cellular Therapy, Sylvester Comprehensive Cancer Center, Miami, Florida.
[20]
Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[21]
Division of Hematology and Oncology, Case Western Reserve University, Cleveland, Ohio.
[22]
Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas.
[23]
Hematology and Cellular Therapy Department, Saint-Antoine Hospital, AP-HP, Sorbonne University, INSERM UMRs 938, Paris, France.
[24]
Division of Blood and Marrow Transplantation, Stanford University, Stanford, California.
[25]
Graft-versus-Host and Late Effects Section, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland.
[26]
Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida. Electronic address: Mohamed@mayo.edu.
[27]
Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York. Electronic address: peralesm@mskcc.org.
[28]
Division of Hematology, Mayo Clinic, Rochester, Minnesota. Electronic address: Lin.Yi@mayo.edu.
[29]
DOI
10.1016/j.bbmt.2019.08.015
PMID
31446199
发布时间
2020-11-13
换一批
换一批
